Chicz, et al., "Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size," Nature, 358:764-768 (1992). |
Ahmed, A.R. et al., Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphiqus vulgaris, Proc. Natl. Acad. Sci. (USA) 87:7658, 1990. |
Alexander J. et al. Functional consequences of engagement of the T cell receptor by low affinity ligands, J. Immunol. 150:1-7, 1993. |
Amagai, M. et al., Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion, Cell 67:869, 1991. |
Amagai, M. et al., Autoantibodies against the amino-terminal cadherin-like binding domain of pemphiqus vulgaris antigen are pathogenic, J. Clin. Invest. 90:919, 1992. |
Brown, J.H. et al., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364:33, 1993. |
Brown, L.R. et al., Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies, I, Site definition and implications for antigen presentation and T lymphocyte recognition, J. Immunol. 147:2677-2684, 1991. |
Busch, R. et al.,.Effect of a natural polymorphism at residue 86 of the HLA-DR .beta. chain on peptide binding. J. Immunol. 147:1292-1298 (1991). |
Chicz, R.M. et al., Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med. 178:27 (1993). |
Gregersen, P.K. et al., The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum. 30, 1205 (1987). |
Hammer, J. et al., Promiscuous and allele-specific anchors in HLA-DR-binding peptides, Cell 74:197 (1993). |
Jardetzky, T.S. et al., Peptide binding to HLA-DR1: A peptide with most residues substituted to alanine retains MHC binding, EMBO J. 9:1797-1803 (1990). |
Jardetzky, T.S. et al., Identification of self peptides bound to purified HLA-B27, Nature 353:326 (1991). |
Lanchbury, J. & G. Panayi, Genetics of RA; the HLA shared epitope hypothesis and its implications, Br. J. Rheumatol. 30(Suppl 2):6 (1991). |
Lehmann, P. et al., Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen, Nature 358:155-157 (1992). |
Madden, D.R. et al., The antigenic identity of peptide-MHC complexes: A comparison of the conformation of five viral peptides presented by HLA-A2, Cell 75:693-708 (1993). |
Marsh, S. and J. Bodmer, HLA class II nucleotide sequences, Human Immunol. 35:1-17 (1992). |
Oldstone, M.B.A., Molecular mimicry and autoimmune disease, Cell 50:819-820 (1990). |
O'Sullivan, D. et al., On the interaction of promiscuous antigenic peptides with different DR alleles: Identification of common structural motifs. J. Immunol. 147:2663 (1991). |
Ota, K. et al., T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis, Nature 346:183-187 (1990). |
Pette, M. et al., Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors, Proc. Natl. Acad. Sci. (USA) 87:7968-7972 (1990). |
Reay, P. et al., Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103), J. Immunol. 150:3946-3957 (1994). |
Rotschke, O. & K. Falk, Origin, structure and motifs of naturally processed MHC class II ligands, Current Opinion Immunol. 6:45 (1994). |
Scharf, S. et al., Sequence analysis of the HLA-DR.beta. and DO.beta. loci from three pemphigus vulgaris patients, Human Immunol, 22:61 (1988). |
Sinha, A. et al., A newly characterized HLA-DO.beta. allele associated with pemphigus vulgaris, Science 239:1026 (1988). |
Steinman, L., Escape from "horror autotoxicus"; Pathogenesis and treatment of autoimmune disease, Cell 80:7-10 (1995). |
Stern, L. et al., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215 (1994). |
Chicz, R. et al., Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size, Nature 358:764 (1992). |
Vogt, A. et al., Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides, J. Immunol. 151:1665-1673 (1994). |
Wucherpfennig, K. et al., T-cell recognition of myelin basic protein, Immunol. Today 12:277-282 (1991). |
Wucherpfennig, K. et al., Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones, J. Exp. Med. 179:279-290 (1994a). |
Wucherpfennig, K. et al., Clonal expansion and peristence of human T cells specific for an immunodominant myelin basic protein peptide, J. Immunol. 150:5581-5592 (1994b). |